High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy: A study of the American Bone Marrow Transplant Group

Steven N. Wolff, Joseph W. Fay, Roger H. Herzig, John P. Greer, Stephen Dummer, Randy A. Brown, Robert H. Collins, Don A. Stevens, Geoffrey P. Herzig